Variables

N (%) or mean ± SD

HFS-14 score (or ρ)

P-value

Gender

Male

55 (52.4)

20.3 ± 18.3

0.51

Female

50 (47.6)

22.8 ± 22.0

Age, y*

62.3 ± 12.0

0.05

0.60

Employment status

Employed

38 (36.2)

27.6 ± 24.1

0.03

Unemployed

67 (63.8)

18.0 ± 16.6

Education

≤12 years

70 (66.7)

22.7 ± 20.9

0.35

12 years

35 (33.3)

19.1 ± 18.2

Cohabitation status

Living with family or other adults

99 (94.3)

21.2 ± 19.3

0.67

Living alone

6 (5.7)

27.0 ± 31.9

ECOG performance status

0

81 (77.1)

23.4 ± 21.8

0.01

1 or 2

24 (22.9)

15.3 ± 11.1

Type of cancer

Breast cancer

35 (33.3)

24.4 ± 20.3

0.22

Colorectal cancer

30 (28.6)

15.5 ± 13.1

Hepatocellular carcinoma

31 (29.5)

22.2 ± 25.0

Renal cell carcinoma

9 (8.6)

27.8 ± 17.5

Anti-cancer agent

Capecitabine

65 (61.9)

20.3 ± 17.8

0.46

Sorafenib or Sunitinib

40 (38.1)

23.5 ± 23.5

Time since treatment, months*

4.6 ± 5.7

0.19

0.05

Depressive symptoms

Yes

32 (30.5)

37.9 ± 22.3

<0.0001

No

73 (69.5)

15.5 ± 15.5

Self-care score for hand foot syndrome

25.8 ± 7.5

−0.21

0.02